St. Jude Medical Reports First Quarter 2016 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall St set for lower open as AI jitters rekindle, oil gains
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- JPMorgan says AI stock selling may be nearing its limit as positioning resets
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Needham & Company Raises Price Target on St. Jude Medical (STJ) Following Strong 1Q Results
April 20, 2016 1:14 PM EDTNeedham & Company reiterated a Strong Buy rating on St. Jude Medical (NYSE: STJ), and raised the price target to $75.00 (from $70.00), following the company's 1Q earnings report. STJ reported revenue of $1.448B, ahead of the consensus estimate of $1.436B. EPS was reported at $0.90 compared to consensus of $0.88.... More
St. Jude Medical (STJ) Tops Q1 EPS by 2c
April 20, 2016 7:16 AM EDTSt. Jude Medical (NYSE: STJ) reported Q1 EPS of $0.90, $0.02 better than the analyst estimate of $0.88. Revenue for the quarter came in at $1.45 billion versus the consensus estimate of $1.43 billion.
GUIDANCE:
St. Jude Medical sees Q2 2016 EPS of $1.05-$1.07, versus the... More



